Immunotherapy strategies for EGFR-mutated advanced NSCLC after EGFR tyrosine-kinase inhibitors failure

BACKGROUND: This study aimed to investigate the efficacy of immunotherapy, as monotherapy or in combination, comparing to chemotherapy with or without anti-angiogenesis for advanced non-small cell lung cancer (NSCLC) patients progressing to epidermal growth factor receptor (EGFR)-tyrosine kinase inh...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xingyuan, Huang, Huayan, Sun, Yingjia, Jiang, Qing, Yu, Yongfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586749/
https://www.ncbi.nlm.nih.gov/pubmed/37869096
http://dx.doi.org/10.3389/fonc.2023.1265236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586749/
https://www.ncbi.nlm.nih.gov/pubmed/37869096
http://dx.doi.org/10.3389/fonc.2023.1265236

Ejemplares similares